Darren Sherman
See Remarks at Orchestra BioMed Holdings Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Orchestra BioMed Holdings Inc., 3 years.
Orchestra BioMed Holdings Inc.
Director · See Remarks
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | Orchestra BioMed Holdings Inc. | Open-market sale | −15,000 | $4.09 | $61,350 |
| Jul 1, 2026 | Orchestra BioMed Holdings Inc. | Open-market sale | −15,000 | $4.27 | $64,050 |
| Jun 1, 2026 | Orchestra BioMed Holdings Inc. | Open-market sale | −15,000 | $3.87 | $58,050 |
| May 28, 2026 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −4,925 | $3.98 | $19,602 |
| Mar 25, 2026 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −33,317 | $4.57 | $152,259 |
| Feb 12, 2026 | Orchestra BioMed Holdings Inc. | Grant or award | +397,000 | — | — |
| Jan 2, 2026 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −5,588 | $4.31 | $24,084 |
| Nov 25, 2025 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −40,340 | $5.35 | $215,819 |
| Sep 3, 2025 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −40,340 | $2.72 | $109,725 |
| Aug 25, 2025 | Orchestra BioMed Holdings Inc. | Open-market purchase | +3,000 | $2.62 | $7,860 |
| Aug 7, 2025 | Orchestra BioMed Holdings Inc. | Grant or award | +120,000 | — | — |
| May 28, 2025 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −45,843 | $2.95 | $135,237 |
| Apr 4, 2025 | Orchestra BioMed Holdings Inc. | Grant or award | +115,708 | — | — |
| Dec 5, 2024 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −31,815 | $5.57 | $177,210 |
| Sep 10, 2024 | Orchestra BioMed Holdings Inc. | Open-market sale | −6,904 | $5.31 | $36,660 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.